Luciana Molinero to Uterine Cervical Neoplasms
This is a "connection" page, showing publications Luciana Molinero has written about Uterine Cervical Neoplasms.
Connection Strength
0.190
-
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04). Int J Gynecol Cancer. 2024 Aug 05; 34(8):1140-1148.
Score: 0.190